Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
While it was thought that most of cerebral creatine is of peripheral origin, AGAT and GAMT are well expressed in CNS where brain cells synthesize creatine. While the creatine transporter SLC6A8 is expressed by microcapillary endothelial cells (MCEC) at blood-brain barrier (BBB), it is absent from their surrounding astrocytes. This raised the concept that BBB has a limited permeability for peripheral creatine, and that the brain supplies a part of its creatine by endogenous synthesis. This review brings together the latest data on creatine and guanidinoacetate transport through BBB and blood-CSF barrier (BCSFB) with the clinical evidence of AGAT-, GAMT- and SLC6A8-deficient patients, in order to delineate a clearer view on the roles of BBB and BCSFB in the transport of creatine and guanidinoacetate between periphery and CNS, and on brain synthesis and transport of creatine. It shows that in physiological conditions, creatine is taken up by CNS from periphery through SLC6A8 at BBB, but in limited amounts, and that CNS also needs its own creatine synthesis. No uptake of guanidinoacetate from periphery occurs at BBB except under GAMT deficiency, but a net exit of guanidinoacetate seems to occur from CSF to blood at BCSFB, predominantly through the taurine transporter TauT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Creatine enters the cytosol through creatine transporters (CRTR) [58,59,60,61].”
From Creatine in health and disease (2021) · cites this paper as [60]
The cited source says what the claim attributes to it.
In the citing paper
“creatine enters the cytosol through a CRTR”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950 · cited 3×
“Cr is distributed by blood to tissues and taken up by cells through a specific Cr transporter, SLC6A8 (gene: SLC6A8), also called CT1, CRT1, CRTR, CTR or CreaT (Wyss and Kaddurah-Daouk 2000).”
BackgroundThe blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
Engelhardt, B., & Sorokin, L. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 778 · cited 3×
“It consists of non-fenestrated microcapillary endothelial cells (MCEC) connected together by tight and adherent junctions that prevent paracellular diffusion of molecules between blood and CNS parenchyma (Engelhardt and Sorokin 2009).”
BackgroundEngaging neuroscience to advance translational research in brain barrier biology
Neuwelt, E. A., Bauer, B., Fahlke, C., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O'Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2995 · Cited by 579 · cited 2×
“Numerous pathological states of the brain lead to changes or disturbances of BBB, that can range from adaptation of transporter expression and activity to a frank rupture of BBB (Engelhardt and Sorokin 2009; Neuwelt et al. 2011).”
BackgroundLooking at the blood–brain barrier: Molecular anatomy and possible investigation approaches
Cardoso, F. L., Brites, D., & Brito, M. A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.003 · Cited by 569 · cited 1×
“…Lausanne, Switzerland e-mail: Olivier.Braissant@chuv.ch and astrocytic feet which cover more than 98% of the surface made by MCEC and pericytes; Cardoso et al. 2010; Neuwelt et al. 2011) and (ii) a specific extracellular matrix which sheathes MCEC, pericytes and astrocytic feet and limits the…”
BackgroundAstrocyte heterogeneity: an underappreciated topic in neurobiology
Zhang, Y., & Barres, B. A. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.06.005 · Cited by 552 · cited 1×
“This is also true for astrocytes, which are known to become reactive in many CNS pathological conditions (Zhang and Barres 2010).”
BackgroundCreatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417 · cited 2×
“…are strongly decreased (<2 μM; normal range: 17-90 μM) (Ensenauer et al. 2004; Schulze et al. 1997; Schulze et al. 2003), while in cortical gray matter total Cr was measured in the 0.2- 1.5 mM range (normal range: 5.5-7.5 mM) (Mancini et al. 2005; Stöckler et al. 1994; Dezortova et al. 2008).”
BackgroundInfluentialX-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
Salomons, G. S., van Dooren, S. J. M., Verhoeven, N. M., Cecil, K. M., Ball, W. S., Degrauw, T. J., & Jakobs, C. (2001) · The American Journal of Human Genetics · doi:10.1086/320595 · Cited by 396 · cited 1×
“SLC6A8 is also expressed throughout the mammalian brain in neurons and oligodendrocytes (Braissant et al. 2001b; Happe and Murrin 1995; Mak et al. 2009; Schloss et al. 1994; Tachikawa et al. 2008).”
BackgroundChoroid plexus: biology and pathology
Wolburg, H., & Paulus, W. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0627-8 · Cited by 375 · cited 2×
“2), located in lateral, third and fourth ventricles, is made by unique apical tight junctions between the choroid plexus epithelial cells (CPEC), which are responsible of the secretion of CSF and also express specific transporters allowing regulated exchanges between CSF and blood (Engelhardt and Sorokin 2009; Spector…”
BackgroundCreatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347 · cited 3×
“In the brain as in most tissues, the creatine (Cr) / phosphocreatine (PCr) / creatine kinase (CK) system plays essential roles to maintain the high energy levels necessary for CNS development and functions, through regeneration and buffering of ATP levels (Brosnan and Brosnan 2007; Wyss and Kaddurah-Daouk 2000).”
BackgroundCreatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG
Hersch, S. M., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., Zhang, L., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194318.74946.b6 · Cited by 313 · cited 1×
“Indeed, Cr administration can exert protective effects in various neurodegenerative processes, including Huntington’s and Parkinson’s diseases (Béard and Braissant 2010; Bender et al. 2006; Hersch et al. 2006; Klein and Ferrante 2007).”
Background
Research works printed but not linked: 2
- Schulze A (2005) Strategies in the treatment of GAMT deficiency. In Jakobs C, Stöckler-Ipsiroglu S, eds; Verhoeven NM, Salomons GS, co-eds. Clinical and molecular aspects of defects in creatine and polyol metabolism. Heilbronn: SPS Verlagsgesellschaft, 19- 33
- Wilcken B, Fagan E, Sim K, Carpenter KH, Salomons GS (2008) Creatine transporter defect: results of 6 months' treatment. J Inher Metab Dis 31(Suppl):70
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
Ammonia toxicity: from head to toe?
Dasarathy, S., Mookerjee, R. P., Rackayova, V., Rangroo Thrane, V., Vairappan, B., Ott, P., & Rose, C. F. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9938-3 · Cited by 288
“Several studies indicate that this microglial activation is correlated with BBB opening and brain edema (Jiang et al. 2009a, 2009b; Rangroo Thrane et al. 2012).”
InfluentialBraissant, O., McLin, V. A., & Cudalbu, C. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9546-2 · Cited by 287
“Using Cr as a neuroprotective agent may be facilitated by the NH4 -induced activity of the Cr transporter SLC6A8 both at BBB and in surrounding astrocytes (Bélanger et al 2007; Braissant et al 2008; Braissant 2012).”
BackgroundSelf-citationCreatine biosynthesis and transport in health and disease
Joncquel-Chevalier Curt, M., Voicu, P.-M., Fontaine, M., Dessein, A.-F., Porchet, N., Mention-Mulliez, K., Dobbelaere, D., Soto-Ares, G., Cheillan, D., & Vamecq, J. (2015) · Biochimie · doi:10.1016/j.biochi.2015.10.022 · Cited by 238
“CNS cells including neurons, microglial cells and astrocytes contribute to intracerebral creatine biosynthesis through cell populations catalyzing only the first AGAT step (A) (22% cells) or the second GAMT step (B) (21% cells) or both steps (C) (12% cells) or none of these steps (44% cells) (these estimations are fro…”
BackgroundCreatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Metadata
- Authors
- Braissant, O.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Braissant, Olivier
- ORCID
- Braissant, Olivier
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 2012-01-18
- Volume
- 35
- Issue
- 4
- Pages
- 655-664
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2026411379
- Cited by
- 112
- References
- 94
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 8 · 2023: 14 · 2022: 9 · 2021: 10 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 12 · 2015: 9 · 2014: 9 · 2013: 7 · 2012: 5
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- IRIS (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A, 130278, 116859, 3100A0)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- creatine transport, blood-brain barrier, blood-CSF barrier, SLC6A8, GAMT deficiency, astrocytes
- MeSH terms
- Animals, Biological Transport, Blood-Brain Barrier, Cerebrospinal Fluid, Creatine, Glycine, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers. https://app.cochat.ai/papers/10.1007/s10545-011-9433-2
- The paper
- Braissant, O. (2012). Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers. Journal of Inherited Metabolic Disease. https://doi.org/10.1007/s10545-011-9433-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.